关于PM2.5对气候相关的COPD严重性的短期中介作用
Huan Minh Tran1, Yuan-Chien Lin2, Feng-Jen Tsai3
1Ph.D. Program in Global Health and Health Security, College of Public Health, Taipei Medical University, Taipei, Taiwan; Faculty of Public Health, Da Nang University of Medical Technology and Pharmacy, Da Nang, Viet Nam.
The Science of the total environment
|August 25, 2023
概括
短期暴露于相对湿度 (RH) 和温度变化显著影响慢性阻塞性肺病 (COPD) 的严重程度. 细颗粒物 (PM2.5) 在COPD患者的环境影响中起到调解作用.
科学领域:
- 环境健康 环境健康
- 肺部医学 肺部医学
- 流行病学 流行病学
背景情况:
- 短期环境因素,如温度,相对湿度 (RH) 和细颗粒物 (PM2.5) 对慢性阻塞性肺病 (COPD) 的影响尚未完全理解.
- 了解这些关系对于管理COPD恶化和改善患者结果至关重要.
研究的目的:
- 研究PM2.5在RH和温度的短期变化与COPD临床结果之间的关联中的调解作用.
- 分析环境RH,温度和PM2.5对COPD患者肺功能和症状严重性的影响.
主要方法:
- 一项涉及930名台湾COPD患者 (2017-2022) 的横截面研究.
- 肺功能评估 (FEV1/FVC),COPD评估测试 (CAT) 评分,以及医学研究理事会 (mMRC) 修改的呼吸障碍量表.
- 估计个人暴露于RH,温度和PM2.5 (1天,7天,30天的平均值和差异) 和使用回归模型进行分析.
主要成果:
- 增加的RH差异与FEV1/FVC的改善有关;增加的温度差异与FEV1和FEV1/FVC的降低相关.
- 增加的PM2.5暴露与FEV1,FVC和FEV1/FVC的下降有关,特别是在寒冷的季节.
- 在寒冷的季节,PM2.5完全介导了平均温度和FEV1/FVC之间的关系,并影响了季节性临床结果的RH和温度效应.
结论:
- PM2.5在温度和RH对COPD临床结果的短期影响中起着重要的调解作用.
- 在低RH,极端温度和高PM2.5水平期间监测COPD患者对于主动管理至关重要.
- 环境因素,特别是PM2.5,显著影响COPD患者的肺功能和症状严重程度.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
COPD: Management Using Bronchodilators and Corticosteroids
244
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
COPD: Pathogenesis and Clinical Features
341
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
341
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K


